Regenerative Medicine is delighted to publish open access original research demonstrating the first virus- and oncogene-free induced pluripotent stem cell (iPSC) technology to produce safer pluripotent stem cells from cord blood and peripheral blood.
06 December, 2018
Virus- and oncogene-free reprogramming method for the production of iPSCs published in the journal Regenerative Medicine
Oncology Central has launched the inaugural Capturing Cancer: Oncology Central Photography Competition – an opportunity to share photos that illustrate cutting-edge research and discoveries being made in the field of oncology.
29 August, 2018
Entries now open for the Capturing Cancer: Oncology Central Photography Competition
The Future Science Group (FSG) published journal, Bioanalysis, which is a leading MEDLINE indexed journal for bioanalysts, today announced the release of its Special Focus Issue on ‘Biomarker Assay Validation (BAV) ’.
27 June, 2018
Bioanalysis publishes special focus issue on ‘Biomarker Assay Validation’
Bioanalysis, a leading MEDLINE indexed journal for bioanalytical scientists, has published a Special Focus Issue on LC–MS assays impacting CYP and transporter DDI evaluations. The journal is published by Future Science Group.
Future Science Group (FSG) is delighted to announce the acquisition of the life sciences journal, BioTechniques, from Informa PLC. BioTechniques joins the growing collection of Future Science Group STM journals.
Future Science Group (FSG) today announced that its journal Personalized Medicine (ISSN 1741-0541) has been selected for coverage by MEDLINE, allowing enhanced discoverability of articles in this important area of research.
17 April, 2018
Personalized Medicine accepted for coverage by MEDLINE